Primary Site >> Colorectal Cancer
Gene >> TPI1
| 1. | |||||||||||
| Journal: | Int J Oncol. 2004 Sep;25(3):571-8. | ||||||||||
| Title: | A novel combination antimetabolite, TAS-102, exhibits antitumor activity in FU-resistant human cancer cells through a mechanism involving FTD incorporation in DNA. | ||||||||||
| Author: | Emura, Tomohiro|Suzuki, Norihiko|Yamaguchi, Masahiro|Ohshimo, Hideyuki|Fukushima, Masakazu | ||||||||||
| PMID: | 15289858 | ||||||||||
| 2. | |||||||||||
| Journal: | Anticancer Drugs. 2005 Mar;16(3):285-92. | ||||||||||
| Title: | Determinants of trifluorothymidine sensitivity and metabolism in colon and lung cancer cells. | ||||||||||
| Author: | Temmink, Olaf H|de Bruin, Michiel|Comijn, Elizabeth M|Fukushima, Masakazu|Peters, Godefridus J | ||||||||||
| PMID: | 15711180 | ||||||||||
| 3. | |||||||||||
| Journal: | Int J Biochem Cell Biol. 2007;39(3):565-75. | ||||||||||
| Title: | Activity and substrate specificity of pyrimidine phosphorylases and their role in fluoropyrimidine sensitivity in colon cancer cell lines. | ||||||||||
| Author: | Temmink, Olaf H|de Bruin, Michiel|Turksma, Annelies W|Cricca, Silvia|Laan, Adrie C|Peters, Godefridus J | ||||||||||
| PMID: | 17098463 | ||||||||||
| 4. | |||||||||||
| Journal: | J Immunol. 2010 Jun 1;184(11):6529-36. | ||||||||||
| Title: | Novel SHP-1 inhibitors tyrosine phosphatase inhibitor-1 and analogs with preclinical anti-tumor activities as tolerated oral agents. | ||||||||||
| Author: | Kundu, Suman|Fan, Keke|Cao, Mingli|Lindner, Daniel J|Zhao, Zhizhaung Joe|Borden, Ernest|Yi, Taolin | ||||||||||
| PMID: | 20421638 | ||||||||||
| 5. | |||||||||||
| Journal: | Mol Cancer Ther. 2010 Aug;9(8):2287-96. | ||||||||||
| Title: | Tyrosine phosphatase inhibitor-3 sensitizes melanoma and colon cancer to biotherapeutics and chemotherapeutics. | ||||||||||
| Author: | Kundu, Suman|Fan, Keke|Cao, Mingli|Lindner, Daniel J|Tuthill, Ralph|Liu, Lili|Gerson, Stanton|Borden, Ernest|Yi, Taolin | ||||||||||
| PMID: | 20682647 | ||||||||||
| 6. | |||||||||||
| Journal: | Exp Ther Med. 2011 May;2(3):393-397. | ||||||||||
| Title: | Trifluorothymidine exhibits potent antitumor activity via the induction of DNA double-strand breaks. | ||||||||||
| Author: | Suzuki, Norihiko|Nakagawa, Fumio|Nukatsuka, Mamoru|Fukushima, Masakazu | ||||||||||
| PMID: | 22977515 | ||||||||||
| 7. | |||||||||||
| Journal: | Br J Cancer. 2012 Jul 24;107(3):429-34. | ||||||||||
| Title: | Phase I study of TAS-102 treatment in Japanese patients with advanced solid tumours. | ||||||||||
| Author: | Doi, T|Ohtsu, A|Yoshino, T|Boku, N|Onozawa, Y|Fukutomi, A|Hironaka, S|Koizumi, W|Sasaki, T | ||||||||||
| PMID: | 22735906 | ||||||||||
| 8. | |||||||||||
| Journal: | World J Gastroenterol. 2014 Sep 7;20(33):11840-9. | ||||||||||
| Title: | Identification of differential proteins in colorectal cancer cells treated with caffeic acid phenethyl ester. | ||||||||||
| Author: | He, Yu-Jun|Li, Wan-Ling|Liu, Bao-Hua|Dong, Hui|Mou, Zhi-Rong|Wu, Yu-Zhang | ||||||||||
| PMID: | 25206290 | ||||||||||
| 9. | |||||||||||
| Journal: | Oncol Rep. 2014 Dec;32(6):2319-26. | ||||||||||
| Title: | Repeated oral dosing of TAS-102 confers high trifluridine incorporation into DNA and sustained antitumor activity in mouse models. | ||||||||||
| Author: | Tanaka, Nozomu|Sakamoto, Kazuki|Okabe, Hiroyuki|Fujioka, Akio|Yamamura, Keisuke|Nakagawa, Fumio|Nagase, Hideki|Yokogawa, Tatsushi|Oguchi, Kei|Ishida, Keiji|Osada, Akiko|Kazuno, Hiromi|Yamada, Yukari|Matsuo, Kenichi | ||||||||||
| PMID: | 25230742 | ||||||||||
| 10. | |||||||||||
| Journal: | Ther Adv Med Oncol. 2015 Nov;7(6):340-56. | ||||||||||
| Title: | Therapeutic potential of TAS-102 in the treatment of gastrointestinal malignancies. | ||||||||||
| Author: | Peters, Godefridus J | ||||||||||
| PMID: | 26557901 | ||||||||||
| 11. | |||||||||||
| Journal: | Invest New Drugs. 2015 Oct;33(5):1068-77. | ||||||||||
| Title: | Phase I study of TAS-102 and irinotecan combination therapy in Japanese patients with advanced colorectal cancer. | ||||||||||
| Author: | Doi, Toshihiko|Yoshino, Takayuki|Fuse, Nozomu|Boku, Narikazu|Yamazaki, Kentaro|Koizumi, Wasaburo|Shimada, Ken|Takinishi, Yasutaka|Ohtsu, Atsushi | ||||||||||
| PMID: | 26163340 | ||||||||||
| 12. | |||||||||||
| Journal: | Int J Oncol. 2015;46(6):2327-34. | ||||||||||
| Title: | Crucial roles of thymidine kinase 1 and deoxyUTPase in incorporating the antineoplastic nucleosides trifluridine and 2'-deoxy-5-fluorouridine into DNA. | ||||||||||
| Author: | Sakamoto, Kazuki|Yokogawa, Tatsushi|Ueno, Hiroyuki|Oguchi, Kei|Kazuno, Hiromi|Ishida, Keiji|Tanaka, Nozomu|Osada, Akiko|Yamada, Yukari|Okabe, Hiroyuki|Matsuo, Kenichi | ||||||||||
| PMID: | 25901475 | ||||||||||
| 13. | |||||||||||
| Journal: | Oncol Rep. 2015 May;33(5):2135-42. | ||||||||||
| Title: | Efficacy of combination chemotherapy using a novel oral chemotherapeutic agent, TAS-102, together with bevacizumab, cetuximab, or panitumumab on human colorectal cancer xenografts. | ||||||||||
| Author: | Tsukihara, Hiroshi|Nakagawa, Fumio|Sakamoto, Kazuki|Ishida, Keiji|Tanaka, Nozomu|Okabe, Hiroyuki|Uchida, Junji|Matsuo, Kenichi|Takechi, Teiji | ||||||||||
| PMID: | 25812794 | ||||||||||
| 14. | |||||||||||
| Journal: | Expert Rev Clin Pharmacol. 2016;9(3):355-65. | ||||||||||
| Title: | A novel antimetabolite: TAS-102 for metastatic colorectal cancer. | ||||||||||
| Author: | Miyamoto, Yuji|Lenz, Heinz-Josef|Baba, Hideo | ||||||||||
| PMID: | 26677869 | ||||||||||
| 15. | |||||||||||
| Journal: | Anticancer Res. 2016 Jan;36(1):21-6. | ||||||||||
| Title: | TAS-102 an Emerging Oral Fluoropyrimidine. | ||||||||||
| Author: | Chen, Jiezhong|Han, Mei|Saif, Muhammad Wasif | ||||||||||
| PMID: | 26722024 | ||||||||||
| 16. | |||||||||||
| Journal: | Clin Cancer Res. 2016 Jun 15;22(12):2835-9. | ||||||||||
| Title: | TAS-102 for Treatment of Advanced Colorectal Cancers That Are No Longer Responding to Other Therapies. | ||||||||||
| Author: | van der Velden, Daphne L|Opdam, Frans L|Voest, Emile E | ||||||||||
| PMID: | 27126991 | ||||||||||
| 17. | |||||||||||
| Journal: | Crit Rev Oncol Hematol. 2016 Aug;104:91-7. | ||||||||||
| Title: | Review on TAS-102 development and its use for metastatic colorectal cancer. | ||||||||||
| Author: | Mota, Jose Mauricio|Fonseca, Leonardo G|Braghiroli, Maria Ignez|Hoff, Paulo M | ||||||||||
| PMID: | 27296058 | ||||||||||
| 18. | |||||||||||
| Journal: | Am J Cancer Res. 2017 Oct 1;7(10):2032-2040. eCollection 2017. | ||||||||||
| Title: | Synergistic anticancer activity of a novel oral chemotherapeutic agent containing trifluridine and tipiracil in combination with anti-PD-1 blockade in microsatellite stable-type murine colorectal cancer cells. | ||||||||||
| Author: | Suzuki, Norihiko|Tsukihara, Hiroshi|Nakagawa, Fumio|Kobunai, Takashi|Takechi, Teiji | ||||||||||
| PMID: | 29119052 | ||||||||||
| 19. | |||||||||||
| Journal: | Am J Cancer Res. 2017 Dec 1;7(12):2577-2586. eCollection 2017. | ||||||||||
| Title: | Combined efficacy and mechanism of trifluridine and SN-38 in a 5-FU-resistant human colorectal cancer cell lines. | ||||||||||
| Author: | Matsuoka, Kazuaki|Takechi, Teiji | ||||||||||
| PMID: | 29312810 | ||||||||||
| 20. | |||||||||||
| Journal: | Anticancer Res. 2018 Mar;38(3):1427-1434. | ||||||||||
| Title: | Pre-exposure to Fluorouracil Increased Trifluridine Incorporation and Enhanced its Anti-tumor Effect for Colorectal Cancer. | ||||||||||
| Author: | Baba, Taisuke|Kokuryo, Toshio|Yamaguchi, Junpei|Yokoyama, Yukihiro|Uehara, Keisuke|Ebata, Tomoki|Nagino, Masato | ||||||||||
| PMID: | 29491068 | ||||||||||
| 21. | |||||||||||
| Journal: | Oncotarget. 2018 Jan 1;9(26):18559-18569. | ||||||||||
| Title: | Identification of specific and common diagnostic antibody markers for gastrointestinal cancers by SEREX screening using testis cDNA phage library. | ||||||||||
| Author: | Kobayashi, Sohei|Hiwasa, Takaki|Arasawa, Takahiro|Kagaya, Akiko|Ishii, Sayaka|Shimada, Hideaki|Ito, Masaaki|Suzuki, Masae|Kano, Masayuki|Rahmutulla, Bahityar|Kitamura, Kouichi|Sawabe, Yuji|Shin, Hideo|Takiguchi, Masaki|Nomura, Fumio|Matsubara, Hisahiro|Ma | ||||||||||
| PMID: | 29719626 | ||||||||||
| 22. | |||||||||||
| Journal: | Clin Colorectal Cancer. 2018 Sep;17(3):e531-e539. | ||||||||||
| Title: | Real-world Treatment Patterns Among Patients With Colorectal Cancer Treated With Trifluridine/Tipiracil and Regorafenib. | ||||||||||
| Author: | Patel, Anuj K|Duh, Mei S|Barghout, Victoria|Yenikomshian, Mihran A|Xiao, Yongling|Wynant, Willy|Tabesh, Majid|Fuchs, Charles S | ||||||||||
| PMID: | 29803544 | ||||||||||
| 23. | |||||||||||
| Journal: | J Cell Physiol. 2018 Nov;233(11):8919-8929. | ||||||||||
| Title: | Triose-phosphate isomerase is a novel target of miR-22 and miR-28, with implications in tumorigenesis. | ||||||||||
| Author: | Lone, Saife Niaz|Maqbool, Raihana|Parray, Fazl Q|Ul Hussain, Mahboob | ||||||||||
| PMID: | 29856481 | ||||||||||
| 24. | |||||||||||
| Journal: | Int J Mol Sci. 2018 Sep 25;19(10). pii: ijms19102915. | ||||||||||
| Title: | Effective Sequential Combined Chemotherapy with Trifluridine/Tipiracil and Regorafenib in Human Colorectal Cancer Cells. | ||||||||||
| Author: | Matsuoka, Kazuaki|Nakagawa, Fumio|Tanaka, Nozomu|Okabe, Hiroyuki|Matsuo, Kenichi|Takechi, Teiji | ||||||||||
| PMID: | 30257515 | ||||||||||